Back
Medifast 10K Form
Sell
35
MED
Medifast
Last Price:
20.51
Seasonality Move:
9.93%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-29 | 10Q | MED/Medifast Quarterly |
| 2023-11-06 | 10Q | MED/Medifast Quarterly |
| 2023-08-07 | 10Q | MED/Medifast Quarterly |
| 2023-05-01 | 10Q | MED/Medifast Quarterly |
| 2022-11-03 | 10Q | MED/Medifast Quarterly |
| 2022-08-03 | 10Q | MED/Medifast Quarterly |
Receive MED News And Ratings
See the #1 stock for the next 7 days that we like better than MED
MED Financial Statistics
Sales & Book Value
| Annual Sales: | $1.07B |
|---|---|
| Cash Flow: | $5.44M |
| Price / Cash Flow: | 2.52 |
| Annual Sales: | $19.29 |
| Price / Book: | 1.01 |
Profitability
| EPS (TTM): | 6.15000 |
|---|---|
| Net Income (TTM): | $67.76M |
| Gross Margin: | $775.85M |
| Return on Equity: | 35.22% |
| Return on Assets: | 21.54% |
Medifast Earnings Forecast
Key Medifast Financial Ratios
- The Gross Profit Margin over the past 28 years for MED is 72.37%.
- The Selling, General & Administrative Expenses for MED have been equal to 60.58% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 0.49% of Operating Income.
- The Net Earning history of MED is 9.27% of Total Revenues.
- Per Share Earnings over the last 28 years have been positive in 15 years.
Medifast Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Personal Care Products |
| Sector: | Consumer Staples |
| Current Symbol: | MED |
| CUSIP: | 58470H |
| Website: | medifastinc.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 2.84 |
| Quick Ratio: | 2.03 |
Price-to-Earnings
| Trailing P/E Ratio: | 2.15 |
|---|---|
| Forward P/E Ratio: | 12.48 |